Bioavailability Enhancement Solutions

Bioavailability - Improve your score rateMore than ever, an active pharmaceutical ingredient’s (API) bioavailability is a key factor to its success. Through improvement of the final formulation you can increase the bioavailability of your API. We support you with solutions that improve poor aqueous solubility, control optimized release profiles and achieve targeted drug delivery to help boost your productivity and return on investment.

With a secure supply chain, a comprehensive formulation portfolio of over 400 Emprove® products, and outstanding global expertise, we can help solve even the trickiest bioavailability challenge. No matter the application or dosage form, our products improve the performance of APIs, so your molecules won’t get stuck in the development pipeline.

Find the right functional excipient to solve your bioavailability challenges:

Optimized ReleaseSolubility EnhancementTargeting and Drug Delivery
Parteck® SRP 80 (Polyvinyl Alcohol) Parteck® MXP Activated/ Functionalized PEGs (Polyethylene Glycols)
Parteck® M (Mannitol) Parteck® SLC (Silica) Lipids/ Synthetic Lipids
Parteck® ODT (Orally Disintegrating Tablet) Meglumine PEG Lipids
Parteck® Delta M (Mannitol) Activated/ Functionalized PEGs PLGA/PLA
PVA (Polyvinyl Alcohol) PEGs (Polyethylene Glycols)  
PEGs (Polyethylene Glycols) Tween®  
PEG Lipids    
Activated/ Functionalized PEGs (Polyethylene Glycols)    

Click here to watch from tablet or mobile device. 
Webinar: Hot Melt Extrusion with PVA: Overcoming Solubility and Bioavailability Challenges

Hot Melt Extrusion with PVA: Overcoming Solubility and Bioavailability Challenges

Watch Now
Critical quality factors of biodegradable polymers for injectable sustained-release formulations

Critical Quality Factors of Biodegradable Polymers for Injectable Sustained-Release Formulations

Watch Now